Edward J Osborne

Title: Edward J. Osborne: Innovator in T Cell Receptor Technology

Introduction

Edward J. Osborne is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of immunology, particularly in the development of methods for determining antigen-specific T cells. His work has implications for cancer research and treatment.

Latest Patents

Edward J. Osborne holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention is directed to methods for determining antigen-specific T cells generally and to T cell receptors that specifically bind an epitope of the Wilms' tumor antigen-1 (WT1) protein. The patent also includes polynucleotides encoding the TCRs, engineered cells exogenously expressing the TCRs, and methods of making and using the TCRs and/or cells expressing the TCRs. He has 1 patent to his name.

Career Highlights

Edward J. Osborne is associated with Adaptive Biotechnologies Corporation, a company that focuses on innovative solutions in the field of biotechnology. His work at the company has been instrumental in advancing the understanding of T cell receptors and their applications in therapeutic settings.

Collaborations

He has collaborated with notable colleagues such as Timothy Lee Hayes and Joyce K. Hu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Edward J. Osborne's contributions to the field of T cell receptor technology highlight his role as a key innovator in immunology. His patent and work at Adaptive Biotechnologies Corporation reflect his commitment to advancing medical science and improving patient outcomes.